AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
7.96
-0.18 (-2.21%)
Apr 1, 2025, 10:33 AM EDT - Market open

AVITA Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 17.25, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 116.71% from the current stock price of 7.96.

Analyst Consensus: Buy
Target Low Average Median High
Price $12 $17.25 $21 $22
Change +50.75% +116.71% +163.82% +176.38%

Analyst Ratings

The average analyst rating for AVITA Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 001222
Buy 111111
Hold 222222
Sell 000000
Strong Sell 000000
Total 334555

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$22
Strong Buy Maintains $22 +176.38% Mar 18, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$25$22
Strong Buy Maintains $25$22 +176.38% Feb 20, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$25
Strong Buy Maintains $25 +214.07% Feb 14, 2025
Lake Street
Lake Street
Strong Buy
Maintains
$20$14
Strong Buy Maintains $20$14 +75.88% Jan 8, 2025
D. Boral Capital
D. Boral Capital
Strong Buy
Maintains
$25
Strong Buy Maintains $25 +214.07% Jan 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
104.03M
from 64.25M
Increased by 61.91%
Revenue Next Year
136.65M
from 104.03M
Increased by 31.36%
EPS This Year
-0.69
from -2.39
EPS Next Year
-0.15
from -0.69
Fiscal Year FY 2021 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Jun 30, 2021 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
29.23M33.03M34.42M50.14M64.25M104.03M136.65M227.03M
Revenue Growth
104.95%12.98%4.23%45.68%28.14%61.91%31.36%66.14%
EPS
-1.17-1.03-1.07-1.40-2.39-0.69-0.152.77
EPS Growth
--------
Forward PE
-------2.87
No. Analysts -----1094
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 110.4M 162.8M 312.9M
Avg 104.0M 136.7M 227.0M
Low 97.9M 121.4M 144.3M

Revenue Growth

Revenue Growth 20252026202720282029
High
71.7%
56.4%
128.9%
Avg
61.9%
31.4%
66.1%
Low
52.4%
16.7%
5.6%

EPS Forecast

EPS 20252026202720282029
High -0.18 0.04 5.69
Avg -0.69 -0.15 2.77
Low -0.99 -0.31 0.01

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.